Arrowhead Research | ARWR - EPS Earnings Per Share


Arrowhead Research reported $0.22 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Dec/2025 0.22 0.04 -1.39 Feb/05 2026
FY2025Q4 Sep/2025 -0.11 -0.23 -1.36 Nov/25 2025
FY2025Q3 Jun/2025 -1.26 -0.86 -1.38 Aug/07 2025
FY2025Q2 Mar/2025 2.75 -0.11 -1.02 May/12 2025
FY2025Q1 Dec/2024 -1.39 -0.39 -1.24 Feb/10 2025




Eps Change Date
Agios Pharmaceuticals USD -1.86 0.08 Dec/2025
Alnylam Pharmaceuticals USD 1.25 1.65 Dec/2025
Anika Therapeutics USD -0.34 1.16 Mar/2025
Arrowhead Research USD 0.22 0.33 Dec/2025
Heron Therapeutics USD -0.03 0.03 Sep/2024
Incyte USD 1.8 0.46 Dec/2025
Ionis Pharmaceuticals USD -0.8 1.5 Sep/2025
Ligand Pharmaceuticals USD 3.09 1.49 Sep/2025
Merck USD 2.04 0.54 Dec/2025
Moderna USD -2.11 1.6 Dec/2025
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Novartis USD 2.04 0.38 Sep/2025
Sarepta Therapeutics USD -0.13 2.15 Sep/2025
TG Therapeutics USD 2.43 2.26 Sep/2025
Ultragenyx Pharmaceutical USD -1.29 0.52 Dec/2025
Vertex Pharmaceuticals USD 5.03 0.23 Dec/2025
Xencor USD -0.08 0.33 Sep/2025